Med Indite Communications , Med Indite Communications
Med Indite Communications , Med Indite Communications
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-14468,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode-title-hidden,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.0.9,qode-theme-bridge,transparent_content,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-5.7,vc_responsive

 Our Services

MIC offers an extensive list of services to accommodate Sponsor’s requirement.

 Our Recent Publications

List of some of the publications that MIC team members authored or supported in recent time.

By admin / November 10, 2022

First-in-Human Study to Evaluate Safety, Tolerabil...

Introduction: AOD01 is a novel, fully human immunoglobulin (Ig) G1 neutralizing monoclonal antibody that was developed as a therapeutic against severe...

Read More
By admin / October 10, 2021

Neem (Azadirachta Indica A. Juss) Capsules for Pro...

Context: SARS-CoV-2 is a global public-health concern. Interventions to prevent infection are urgently needed. The anti-inflammatory and antiviral effects of neem...

Read More
By admin / August 20, 2020

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3...

Tenalisib (RP6530), a dual phosphoinositide 3-kinase δ/γ inhibitor was evaluated in a phase I/Ib study for maximum tolerated dose (MTD),...

Read More
By admin / September 16, 2019

Efficacy of an Ayurvedic Formulation for Mild-to-m...

Current treatment options offer only symptomatic pain relief for patients with osteoarthritis (OA). Thus, a need exists for effective treatment...

Read More
By admin / June 7, 2019

A pandemic influenza vaccine in India: from strain...

In the event of a highly pathogenic influenza pandemic, the Indian subcontinent would need 1.2 billion doses of vaccine to...

Read More
By admin / June 7, 2019

Diphtheria, Tetanus, and Pertussis Immunity in Ind...

Rise of diphtheria cases in adults is a cause of concern worldwide. Pertussis is also now affecting adults. We assessed...

Read More
1 2

About MIC

We are here to fill a gap in technical expertise and medical knowledge for transformative outcomes in clinical research

MIC is established to fill a gap in technical expertise and medical knowledge for transformative outcomes in clinical research for betterment of patients. As a ‘specialized’ service provider we provide a higher level of scientific engagement, medical expertise and value to our clients through thought leadership, deep domain knowledge, and a scientifically focus approach. Our focus has always been on partnering and working closely with each client to build scientifically robust concepts to achieve better outcomes, increase operational efficiencies and ensure consistent regulatory compliance.


MIC has created a cost and resource-optimized business model, affording them the flexibility and scalability to tap into a talent with a diverse skill-set. The firm is a service provider for the biotech generic pharmaceutical, medical device and contract research industry in the areas of clinical development, safety & risk management, regulatory affairs and scientific writing services.

Call To Action

 What Our Users Say

 From The Statistical Analysis


Statistical analyses


Clinical Study Protocols


Clinical Study






Conference Posters/abstracts

 From The Blog

List of some of the interesting scientific blogs created by MIC’s Medical Experts.